Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin

American Journal of Pathology

Volumn 167, Issue 5, 2005, Pages 1267-1277

  Lawson, William E ^a,b   Polosukhin, Vasiliy V ^a   Stathopoulos, Georgios T ^a   Zoia, Ornella ^a   Han, Wei ^a   Lane, Kirk B ^a   Li, Bo ^a   Donnelly, Edwin F ^a   Holburn, George E ^a   Lewis, Kenneth G ^a   Collins, Robert D ^a   Hull, William M ^c   Glasser, Stephan W ^c   Whitsett, Jeffrey A ^c   Blackwell, Timothy S ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN; SURFACTANT PROTEIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DAMAGE; CONTROLLED STUDY; FAMILIAL DISEASE; GENE; GENE DELETION; GENE MUTATION; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG INTERSTITIUM; LUNG PARENCHYMA; MORTALITY; MOUSE; NEUTROPHIL; NICK END LABELING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SFTPC GENE; STAINING; WEIGHT REDUCTION; WILD TYPE;

EID: 27544476860     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61214-X     Document Type: Article

References (55)

1. Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med 2001, 345:517-525
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000, 161:646-664
3. Marshall RP, McAnulty RJ, Laurent GJ: The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? Int J Biochem Cell Biol 1997, 29:107-120
4. Marshall RP, Puddicombe A, Cookson WO, Laurent GJ: Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000, 55:143-146
5. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG: Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med 1986, 314:1343-1347
6. Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002, 57:338-342
7. Nogee LM, Dunbar III AE, Wert SE, Askin F, Hamvas A, Whitsett JA: A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001, 344:573-579
8. Amin RS, Wert SE, Baughman RP, Tomashefski Jr JF, Nogee LM, Brody AS, Hull WM, Whitsett JA: Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 2001, 139:85-92
9. Nogee LM, Dunbar III AE, Wert S, Askin F, Hamvas A, Whitsett JA: Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002, 121:20S-21S
10. Thomas AQ, Lane K, Phillips III J, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, Roberts R, Haines J, Stahlman M, Loyd JE: Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002, 165:1322-1328
11. Weaver TE: Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1998, 1408:173-179
12. Beers MF, Mulugeta S: Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 2005, 67:663-696
13. Lazo JS, Hoyt DG, Sebti SM, Pitt BR: Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther 1990, 47:347-358
14. Bowden DH: Unraveling pulmonary fibrosis: the bleomycin model. Lab Invest 1984, 50:487-488
15. Phan SH, Kunkel SL: Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992, 18:29-43
16. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994, 145:114-125
17. Glasser SW, Burhans MS, Korfhagen TR, Na CL, Sly PD, Ross GF, Ikegami M, Whitsett JA: Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001, 98:6366-6371
18. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995, 130:393-405
19. Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG, Blackwell TS: Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 2005, 171:899-907
20. Hoff CR, Perkins DR, Davidson JM: Elastin gene expression is up-regulated during pulmonary fibrosis. Connect Tissue Res 1999, 40:145-153
21. Blackwell TS, Lancaster LH, Blackwell TR, Venkatakrishnan A, Christman JW: Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats. Am J Respir Crit Care Med 1999, 159:1644-1652
22. Pryhuber GS, Hull WM, Fink I, McMahan MJ, Whitsett JA: Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991, 30:597-605
23. Akinbi HT, Breslin JS, Ikegami M, Iwamoto HS, Clark JC, Whitsett JA, Jobe AH, Weaver TE: Rescue of SP-B knockout mice with a truncated SP-B proprotein. Function of the C-terminal propeptide. J Biol Chem 1997, 272:9640-9647
24. Noah TL, Murphy PC, Alink JJ, Leigh MW, Hull WM, Stahlman MT, Whitsett JA: Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 2003, 168:685-691
25. Okada H, Danoff TM, Kalluri R, Neilson EG: Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997, 273:F563-F574
26. Okada H, Danoff TM, Fischer A, Lopez-Guisa JM, Strutz F, Neilson EG: Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene. Am J Physiol 1998, 275:F306-F314
27. Iwano M, Fischer A, Okada H, Plieth D, Xue C, Danoff TM, Neilson EG: Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 2001, 3:149-159
28. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002, 110:341-350
29. Weaver TE, Conkright JJ: Function of surfactant proteins B and C. Annu Rev Physiol 2001, 63:555-578
30. Glasser SW, Detmer EA, Ikegami M, Na CL, Stahlman MT, Whitsett JA: Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 2003, 278:14291-14298
31. Ikegami M, Weaver TE, Conkright JJ, Sly PD, Ross GF, Whitsett JA, Glasser SW: Deficiency of SP-B reveals protective role of SP-C during oxygen lung injury. J Appl Physiol 2002, 92:519-526
32. Hawgood S, Ogawa A, Yukitake K, Schlueter M, Brown C, White T, Buckley D, Lesikar D, Benson B: Lung function in premature rabbits treated with recombinant human surfactant protein-C. Am J Respir Crit Care Med 1996, 154:484-490
33. Davis AJ, Jobe AH, Hafner D, Ikegami M: Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 1998, 157:553-559
34. Hafner D, Germann PG, Hauschke D: Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury. Am J Respir Crit Care Med 1998, 158:270-278
35. Lewis J, McCaig L, Hafner D, Spragg R, Veldhuizen R, Kerr C: Dosing and delivery of a recombinant surfactant in lung-injured adult sheep. Am J Respir Crit Care Med 1999, 159:741-747
36. Spragg RG, Smith RM, Harris K, Lewis J, Hafner D, Germann P: Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. J Appl Physiol 2000, 88:674-681
37. Floros J, Hoover RR: Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998, 1408:312-322
38. Hay J, Shahzeidi S, Laurent G: Mechanisms of bleomycin-induced lung damage. Arch Toxicol 1991, 65:81-94
39. Savani RC, Godinez RI, Godinez MH, Wentz E, Zaman A, Cui Z, Pooler PM, Guttentag SH, Beers MF, Gonzales LW, Ballard PL: Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C. Am J Physiol 2001, 281:L685-L696
40. Schmidt R, Ruppert C, Markart P, Lubke N, Ermert L, Weissmann N, Breithecker A, Ermert M, Seeger W, Gunther A: Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis. Toxicol Appl Pharmacol 2004, 195:218-231
41. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N: Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997, 16:91-101
42. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999, 104:13-19
43. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD: Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol 2000, 279:L143-L151
44. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N: Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol 2001, 280:L316-L325
45. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, Homer RJ, Elias JA: Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 2004, 200:377-389
46. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M: Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998, 275:L1192-L1199
47. Uhal BD: Apoptosis in lung fibrosis and repair. Chest 2002, 122:2933-2983
48. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N: P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996, 154:477-483
49. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136-151
50. Whitsett JA, Weaver TE: Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002, 347:2141-2148
51. Nogee LM: Abnormal expression of surfactant protein C and lung disease. Am J Respir Cell Mol Biol 2002, 26:641-644
52. Beers MF, Lomax CA, Russo SJ: Synthetic processing of surfactant protein C by alevolar epithelial cells. The COOH terminus of proSP-C is required for post-translational targeting and proteolysis. J Biol Chem 1998, 273:15287-15293
53. Keller A, Steinhilber W, Schafer KP, Voss T: The C-terminal domain of the pulmonary surfactant protein C precursor contains signals for intracellular targeting. Am J Respir Cell Mol Biol 1992, 6:601-608
54. Mulugeta S, Nguyen V, Russo SJ, Muniswamy M, Beers MF: A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 2005, 32:521-530
55. Bridges JP, Wert SE, Nogee LM, Weaver TE: Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 2003, 278:52739-52746